Atossa Therapeutics (NASDAQ:ATOS – Get Rating) will be releasing its earnings data on Monday, May 15th. Atossa Therapeutics (NASDAQ:ATOS – Get Rating) last announced its quarterly earnings results on Wednesday, March 22nd. The company reported ($0.06) earnings per share (EPS) for the quarter. Atossa Therapeutics Stock Performance NASDAQ:ATOS opened at $0.70 on Friday. The firm […]
Atossa Therapeutics, Inc. (NASDAQ:ATOS – Get Rating) shares crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.75 and traded as low as $0.72. Atossa Therapeutics shares last traded at $0.74, with a volume of 238,002 shares traded. Wall Street Analysts […]
Atossa Therapeutics, Inc. (NASDAQ:ATOS – Get Rating)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.75 and traded as low as $0.72. Atossa Therapeutics shares last traded at $0.74, with a volume of 238,002 shares. Analyst Upgrades and Downgrades Separately, StockNews.com raised […]
StockNews.com upgraded shares of Atossa Therapeutics (NASDAQ:ATOS – Get Rating) to a sell rating in a research note published on Thursday morning. Atossa Therapeutics Stock Up 2.5 % Shares of Atossa Therapeutics stock opened at $0.70 on Thursday. The company has a market capitalization of $88.18 million, a price-to-earnings ratio of -3.32 and a beta […]
Atossa Therapeutics (NASDAQ:ATOS – Get Rating) issued its quarterly earnings results on Wednesday. The company reported ($0.06) earnings per share for the quarter, Yahoo Finance reports. Atossa Therapeutics Stock Down 5.1 % ATOS stock opened at $0.68 on Friday. Atossa Therapeutics has a one year low of $0.50 and a one year high of $1.54. […]